Navigation Links
The Female Health Company Repurchases 130,000 Shares of Common Stock in Open Market

CHICAGO, Aug. 7, 2014 /PRNewswire/ -- The Female Health Company (NASDAQ-CM: FHCO) today announced the repurchase of 130,000 shares of its outstanding common stock between August 4 and August 6, 2014, as authorized under the Company's stock repurchase program. The program authorizes the repurchase of up to three million shares of common stock and expires December 31, 2014.  To date, the Company has repurchased approximately 2.2 million common shares under this program, and approximately 0.8 million shares remain for potential repurchase.

Management believes the Company's common stock is currently undervalued in the market and that the current share price does not reflect the Company's intrinsic value or its prospects for long-term growth in revenue and earnings. Future repurchases of shares may be considered when management believes it is in the best interests of shareholders.

In addition, three of the Company's officers and/or directors have purchased FHCO shares in the open market since August 4, 2014 when the trading window opened under the Company's insider trading policy. For additional information on insider purchases, see separate Form 4's filed by the officers or directors with the Securities and Exchange Commission.

About The Female Health Company

The Female Health Company, based in Chicago, Illinois, manufactures and markets the FC2 Female Condom® (FC2). Since the Company began distributing FC2 in 2007, it has been shipped to 144 countries. The Company owns certain worldwide rights to the FC2 Female Condom®, including patents that have been issued in a number of countries around the world. The patents cover the key aspects of FC2, including its overall design and manufacturing process.  The FC2 Female Condom® is the only currently available female-controlled product approved by the FDA that offers dual protection against sexually transmitted infections, including HIV/AIDS, and unintended pregnancy. The World Health Organization (WHO) has cleared FC2 for purchase by U.N. agencies. 

Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995:

The statements in this release which are not historical facts are "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995.  Forward-looking statements in this release include statements regarding future repurchases under the stock repurchase program and the Company's prospects for long-term growth in revenues and earnings.  Repurchases under the stock repurchase program will depend upon market prices, trading volume, available cash and other factors, and, therefore, there is no guarantee as to the number of shares that may be purchased.  These statements are based upon the Company's current plans and strategies, and reflect the Company's current assessment of the risks and uncertainties related to its business, and are made as of the date of this release.  The Company assumes no obligation to update any forward-looking statements contained in this release as a result of new information or future events, developments or circumstances.  Such forward-looking statements are inherently subject to known and unknown risks and uncertainties.  The Company's actual results and future developments could differ materially from the results or developments expressed in, or implied by, these forward-looking statements.  Factors that may cause actual results to differ materially from those contemplated by such forward-looking statements include, but are not limited to, the following:  product demand and market acceptance; competition in the Company's markets and the risk of new competitors and new competitive product introductions; government contracting risks, including the appropriations process and funding priorities, potential bureaucratic delays in awarding contracts, process errors, politics or other pressures, and the risk that government tenders and contracts may be subject to cancellation, delay or restructuring; the Company's reliance on its international partners in the consumer sector and on the level of spending on the female condom by country governments, global donors and other public health organizations in the global public sector; the economic and business environment and the impact of government pressures; risks involved in doing business on an international level, including currency risks, regulatory requirements, political risks, export restrictions and other trade barriers; the Company's production capacity, efficiency and supply constraints; the Company's ability to identify, successfully negotiate and complete suitable acquisitions or other strategic initiatives, the Company's ability to successfully integrate acquired businesses, technologies or products; and other risks detailed in the Company's press releases, shareholder communications and Securities and Exchange Commission filings, including the Company's Form 10-K for the year ended September 30, 2013.  Actual events affecting the Company and the impact of such events on the Company's operations may vary from those currently anticipated.

For more information about the Female Health Company visit the Company's website at and If you would like to be added to the Company's e-mail alert list, please send an e-mail to

Logo -

SOURCE The Female Health Company
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. The Female Health Company To Report Fourth Quarter Operating Results on Tuesday, December 3, 2013
2. Michael Walton Retires From The Female Health Company Board of Directors
3. Hair Restoration Center Announces New Female Medical Hair Restoration
4. Andrew Love Joins The Female Health Company Board of Directors
5. Dr. Carlos Puig Leads Female Hair Replacement Cowgirl Workshop
6. The Female Health Company Executes On Commitment Made At London Summit On Family Planning
7. The Female Health Company Reports Record First Quarter FY2013 Operating Results
8. The Female Health Company To Report First Quarter Operating Results on Wednesday, January 30, 2013
9. The Female Health Company Reports Record Fourth Quarter and FY2012 Operating Results
10. The Female Health Company to Report FY2012 Operating Results on Tuesday, December 4, 2012
11. Palatin Technologies Announces Last Patient Completed Treatment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial
Post Your Comments:
(Date:11/30/2015)... Nov. 30, 2015  Kevin Smith has been ... a global pioneer in wireless monitoring of vital ... MA , Mr. Smith will be responsible ... commercial strategy.  He will also directly oversee partnering ... clinical evidence for SensiumVitals, the first early warning ...
(Date:11/30/2015)... and SAN DIEGO , Nov. 30, ... (NASDAQ: ARNA ) today announced that the U.S. ... the New Drug Application (NDA) for an extended release ... will offer patients a chronic weight management treatment in ... is currently approved as an adjunct to a reduced-calorie ...
(Date:11/30/2015)... N.H. , Nov. 30, 2015 ... that it will feature its latest solutions for ... early identification of cancer at the Radiological Society ... Chicago from November 29 ... recent product advances including iReveal®, an automated breast ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... 2015 , ... MOSI recently added two state-of-the-art augmented reality (AR) experiences from ... to their collection of interactive exhibits within the Kids In Charge! building. In collaboration ... to get closer than ever to a range of animals as they drink, sleep ...
(Date:11/30/2015)... CA (PRWEB) , ... November 30, 2015 , ... The ... grafts, strip harvesting and follicular unit extraction. These techniques and procedures have been in ... patients suffering from hair loss. While Dr. Parsa Mohebi, M.D. has utilized many of ...
(Date:11/30/2015)... ... November 30, 2015 , ... On Saturday, October 24th, ... Society held an annual fundraising event, a 5K walk known as “Making Strides Against ... for substance abuse which is also located in Battle Creek, joined in for this ...
(Date:11/30/2015)... ... , ... The presidential race normally deals with political issues of national importance ... news story when Donald Trump makes disparaging remarks about Hillary Clinton’s hairstyle? It is ... wants to admit when it comes to how people are viewed by others. , ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... According to ... James Decker made a brave but slightly unusual choice to show her Instagram followers ... her pre-pregnancy form may have been pre-mature. Saying that she didn’t “want to mislead ...
Breaking Medicine News(10 mins):